A multi-center self-assessment survey was conducted to evaluate patient satisfaction with the Advanced Bionics Neptune™ waterproof sound processor used with the AquaMic™ totally submersible microphone. Subjective satisfaction with the different Neptune™ wearing options, comfort, ease of use, sound quality and use of the processor in a range of active and water related situations were assessed for 23 adults and 73 children, using an online and paper based questionnaire. Upgraded subjects compared their previous processor to the Neptune™. The Neptune™ was most popular for use in general sports and in the pool. Subjects were satisfied with the sound quality of the sound processor outside and under water and following submersion. Seventy-eight percent of subjects rated waterproofness as being very useful and 83% of the newly implanted subjects selected waterproofness as one of the reasons why they chose the Neptune™ processor. Providing a waterproof sound processor is considered by cochlear implant recipients to be useful and important and is a factor in their processor choice. Subjects reported that they were satisfied with the Neptune™ sound quality, ease of use and different wearing options.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988096 | PMC |
| http://dx.doi.org/10.4081/audiores.2016.146 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rehabilitation of human hearing with a totally implantable cochlear implant: a feasibility study.
Commun Med (Lond)
January 2025
MED-EL Elektromedizinische Geräte GmbH, Fürstenweg 77a, 6020, Innsbruck, Austria.
Background: Cochlear implants (CIs) are neuroprosthetic devices which restore hearing in severe-to-profound hearing loss through electrical stimulation of the auditory nerve. Current CIs use an externally worn audio processor. A long-term goal in the field has been to develop a device in which all components are contained within a single implant.
View Article and Find Full Text PDFAn electrically-evoked compound action potential marker for local spiral ganglion neuron degeneration: The Failure Index.
J Neurosci
December 2024
Department of Experimental Otology, Hannover Medical School, Stadtfelddamm 34, 30625 Hannover, Germany.
Article Synopsis
- Spiral ganglion neuron (SGN) degeneration may lead to poorer hearing outcomes in cochlear implant (CI) users, but there's no existing method to locate these degenerated areas in patients.
- Research on guinea pigs showed that small cochlear micro-lesions significantly increased electrical thresholds and lowered eCAP amplitudes, with effects noticeable up to 3.5 mm away from the lesions.
- A new electrophysiological marker called the Failure Index (FI) was developed, which accurately indicates the presence and proximity of SGN degeneration and demonstrates a high classification accuracy in identifying affected areas, making it a promising tool for clinical applications.
Speech Perception Ability and Subjective Satisfaction After Upgrade of Speech Processor in Cochlear Implantation.
Ear Nose Throat J
November 2024
Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Cochlear implant (CI) users face the decision of whether to upgrade to a new sound processor (SP) with technological advances. We wanted to assess the changes of speech perception ability and aided hearing thresholds as well as subjective satisfaction after upgrade to a new SP. Fifty-five patients who have used CI for 10 years or more and upgraded to a new SP were enrolled.
View Article and Find Full Text PDFFeasibility of snapshot testing using wearable sensors to detect cardiorespiratory illness (COVID infection in India).
NPJ Digit Med
October 2024
Max Nader Lab for Rehabilitation Technologies and Outcomes Research, Shirley Ryan AbilityLab, Chicago, IL, USA.
The COVID-19 pandemic has challenged the current paradigm of clinical and community-based disease detection. We present a multimodal wearable sensor system paired with a two-minute, movement-based activity sequence that successfully captures a snapshot of physiological data (including cardiac, respiratory, temperature, and percent oxygen saturation). We conducted a large, multi-site trial of this technology across India from June 2021 to April 2022 amidst the COVID-19 pandemic (Clinical trial registry name: International Validation of Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms; NCT05334680; initial release: 04/15/2022).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!